AR021782A1 - Derivados de la 2-oxo-2h-quinoleina, un procedimiento para su preparacion, el empleo de los mismos para preparar un medicamento, las composicionesfarmaceuticas que los contienen y un procedimiento para preparar estas composiciones farmaceuticas. - Google Patents
Derivados de la 2-oxo-2h-quinoleina, un procedimiento para su preparacion, el empleo de los mismos para preparar un medicamento, las composicionesfarmaceuticas que los contienen y un procedimiento para preparar estas composiciones farmaceuticas.Info
- Publication number
- AR021782A1 AR021782A1 ARP990104301A ARP990104301A AR021782A1 AR 021782 A1 AR021782 A1 AR 021782A1 AR P990104301 A ARP990104301 A AR P990104301A AR P990104301 A ARP990104301 A AR P990104301A AR 021782 A1 AR021782 A1 AR 021782A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- procedure
- formula
- derivatives
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19839499A DE19839499A1 (de) | 1998-08-29 | 1998-08-29 | 2-Oxo-2H-chinolinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021782A1 true AR021782A1 (es) | 2002-08-07 |
Family
ID=7879227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104301A AR021782A1 (es) | 1998-08-29 | 1999-08-27 | Derivados de la 2-oxo-2h-quinoleina, un procedimiento para su preparacion, el empleo de los mismos para preparar un medicamento, las composicionesfarmaceuticas que los contienen y un procedimiento para preparar estas composiciones farmaceuticas. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1107954A1 (de) |
| JP (1) | JP2002523494A (de) |
| KR (1) | KR20010072862A (de) |
| CN (1) | CN1315942A (de) |
| AR (1) | AR021782A1 (de) |
| AU (1) | AU5164199A (de) |
| BR (1) | BR9913140A (de) |
| CA (1) | CA2342230A1 (de) |
| DE (1) | DE19839499A1 (de) |
| HK (1) | HK1042478A1 (de) |
| HU (1) | HUP0103212A3 (de) |
| ID (1) | ID27863A (de) |
| NO (1) | NO20010996D0 (de) |
| PL (1) | PL346045A1 (de) |
| SK (1) | SK2652001A3 (de) |
| WO (1) | WO2000012479A1 (de) |
| ZA (1) | ZA200102565B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
| ES2896400T3 (es) | 2014-08-01 | 2022-02-24 | Nuevolution As | Compuestos activos frente a bromdominios |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI59246C (fi) * | 1974-06-24 | 1981-07-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin |
| IE43079B1 (en) * | 1975-03-20 | 1980-12-17 | Ici Ltd | Quinolone derivatives |
| JPS596858B2 (ja) * | 1975-04-30 | 1984-02-15 | オオツカセイヤク カブシキガイシヤ | ３，４−ジヒドロカルボスチリル誘導体の製造法 |
| AT347956B (de) * | 1976-03-18 | 1979-01-25 | Ici Ltd | Verfahren zur herstellung von neuen chinol-2- on-4-yl-alkansaeuren und von deren basenadditionssalzen |
| DE2651581A1 (de) * | 1976-11-12 | 1978-05-18 | Merck Patent Gmbh | Chinolonderivate und verfahren zu ihrer herstellung |
| AU8448491A (en) * | 1990-09-07 | 1992-03-30 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| CA2091172C (en) * | 1990-09-07 | 1997-05-20 | Adriano Afonso | Antiviral compounds and antihypertensive compounds |
| ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| DE4208304A1 (de) * | 1992-03-16 | 1993-09-23 | Merck Patent Gmbh | 2-oxochinolinderivate |
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
| DE19530996A1 (de) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel |
| US5968959A (en) * | 1997-12-12 | 1999-10-19 | Orion Corporation | Method for the prevention and treatment of stunned myocardium |
-
1998
- 1998-08-29 DE DE19839499A patent/DE19839499A1/de not_active Withdrawn
-
1999
- 1999-07-26 JP JP2000567512A patent/JP2002523494A/ja active Pending
- 1999-07-26 HU HU0103212A patent/HUP0103212A3/hu unknown
- 1999-07-26 PL PL99346045A patent/PL346045A1/xx unknown
- 1999-07-26 AU AU51641/99A patent/AU5164199A/en not_active Abandoned
- 1999-07-26 WO PCT/EP1999/005315 patent/WO2000012479A1/de not_active Application Discontinuation
- 1999-07-26 CA CA002342230A patent/CA2342230A1/en not_active Abandoned
- 1999-07-26 ID IDW20010680A patent/ID27863A/id unknown
- 1999-07-26 SK SK265-2001A patent/SK2652001A3/sk unknown
- 1999-07-26 KR KR1020017002261A patent/KR20010072862A/ko not_active Application Discontinuation
- 1999-07-26 EP EP99936606A patent/EP1107954A1/de not_active Withdrawn
- 1999-07-26 BR BR9913140-4A patent/BR9913140A/pt not_active Application Discontinuation
- 1999-07-26 CN CN99810283A patent/CN1315942A/zh active Pending
- 1999-08-27 AR ARP990104301A patent/AR021782A1/es unknown
-
2001
- 2001-02-27 NO NO20010996A patent/NO20010996D0/no not_active Application Discontinuation
- 2001-03-28 ZA ZA200102565A patent/ZA200102565B/en unknown
-
2002
- 2002-03-25 HK HK02102249.3A patent/HK1042478A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103212A3 (en) | 2002-06-28 |
| DE19839499A1 (de) | 2000-03-02 |
| NO20010996L (no) | 2001-02-27 |
| ZA200102565B (en) | 2002-06-28 |
| HK1042478A1 (zh) | 2002-08-16 |
| PL346045A1 (en) | 2002-01-14 |
| CA2342230A1 (en) | 2000-03-09 |
| CN1315942A (zh) | 2001-10-03 |
| WO2000012479A1 (de) | 2000-03-09 |
| KR20010072862A (ko) | 2001-07-31 |
| HUP0103212A2 (hu) | 2002-05-29 |
| BR9913140A (pt) | 2001-05-08 |
| SK2652001A3 (en) | 2001-09-11 |
| AU5164199A (en) | 2000-03-21 |
| ID27863A (id) | 2001-04-26 |
| JP2002523494A (ja) | 2002-07-30 |
| NO20010996D0 (no) | 2001-02-27 |
| EP1107954A1 (de) | 2001-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2103709T3 (es) | Uso de inhibidores de peptidasa para la preparacion de medicamentos utiles en el tratamiento de la apoplejia. | |
| KR970707069A (ko) | 매트릭스 금속프로테아제 억제제로서 치환된 4-비아릴부티르산 또는 5-비아릴펜탄산 및 그의 유도체(substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metallorotease inhibitors) | |
| ES2102668T3 (es) | Composiciones detergentes liquidas que contienen proteasa y ciertos acidos y esteres beta-aminoalquilboronicos. | |
| SE9203825D0 (sv) | Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them | |
| ES2133504T3 (es) | Derivados peptidicos del acido boronico con una actividad inhibidora de proteasa, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| AR051315A1 (es) | Pirimidinas 5-sustituidas inhibidoras del vih | |
| HUP0104164A2 (hu) | XA faktor inhibitor hatású imidazo[4,5-c]piridin-4-on származékok, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| AR036187A1 (es) | Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario | |
| AR022220A1 (es) | Derivados de la imidazo[4,5-c]-piridin-4-ona, un procedimiento para su preparacion, el empleo de los mismos para preparar un medicamento, los medicamentosa base de estos compuestos, las composiciones farmaceuticas que contienen estos compuestos y un procedimiento para preparar estas composiciones fa | |
| AR021782A1 (es) | Derivados de la 2-oxo-2h-quinoleina, un procedimiento para su preparacion, el empleo de los mismos para preparar un medicamento, las composicionesfarmaceuticas que los contienen y un procedimiento para preparar estas composiciones farmaceuticas. | |
| AR035133A1 (es) | Composicion topica para suministro folicular de un inhibidor de ornitina descarboxilasa | |
| AR044175A1 (es) | Compuestos de cefemo | |
| NO954381L (no) | Nye aryloksymetyloksazoliner, fremgangsmåte ved deres fremstilling og farmasöytiske preparater inneholdende dem | |
| UY26845A1 (es) | Derivados de la pirimidina | |
| AR023496A1 (es) | Derivados del dibenzoazuleno, sus enantiomeros o diastereomeros, un procedimiento para su preparacion, el empleo de los mismos como sustancias activasterapeuticas y para preparar un medicamento, las composiciones farmaceuticas que los contienen, y un procedimiento para preparar estas composicionesfa | |
| RU2001106998A (ru) | Производные 2-оксо-2н-хинолина | |
| TH64881A (th) | สารประกอบวงไพริมิดีนถูกหลอมรวมที่ถูกอัลไคนิเลทด์ | |
| ECSP003860A (es) | Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| AR004401A1 (es) | Derivados de la tirosina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen. |